South Korea reported that 48 died on Saturday after being vaccinated against the flu, but said the state vaccination program would continue as no direct link between the deaths and the vaccinations was found.
No deaths related to influenza vaccinations have been reported in Singapore so far, but the decision to stop using SKYCellflu Quadrivalent and VaxigripTetra was a precautionary measure, the Department of Health and Health Sciences Authority (HAS) said in a statement late Sunday.
The HSA is liaising with the South Korean authorities for more information to determine if the deaths are related to influenza vaccinations.
SKYCellflu Quadrivalent is manufactured by SK Bioscience in South Korea and sold locally by AJ Biologics, while VaxigripTetra is manufactured by Sanofi and sold locally by Sanofi Aventis.
Two other influenza vaccines brought to Singapore for the northern hemisphere’s 2020-21 influenza season could still be used, according to Singapore health officials.
These were the details of the news Singapore stops using flu vaccines after 48 people died in South... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at de24.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
